Vivanza Biosciences Ltd - Stock Valuation and Financial Performance

BSE: 530057 | NSE: | Trading | Small Cap

Vivanza Biosciences Share Price

6.79 0.31 4.78%
as on 28-Mar'24 16:01

DeciZen - make an informed investing decision on Vivanza Biosciences

M-Cap below 100cr DeciZen not available

Vivanza Biosciences stock performance -

mw4me loader
P/E Ratio (SA):
40.63
Market Cap:
25.9 Cr.
52-wk low:
5.7
52-wk high:
17.9

Is Vivanza Biosciences Ltd an attractive stock to invest in?

1. Is Vivanza Biosciences Ltd a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Vivanza Biosciences Ltd is a below average quality company.

2. Is Vivanza Biosciences Ltd undervalued or overvalued?

The key valuation ratios of Vivanza Biosciences Ltd's currently when compared to its past seem to suggest it is in the Fair zone.

3. Is Vivanza Biosciences Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Vivanza Biosciences Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Vivanza Biosciences:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Vivanza Biosciences Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Value Creation Index Colour Code Guide

Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23TTM
ROCE % -8.7%-8.4%-10.3%-6%11.2%-3.4%2.7%12.4%14.3%9.3%-
Value Creation
Index
-1.6-1.6-1.7-1.4-0.2-1.2-0.8-0.10.0-0.3-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 0003.56.42.29.49.29.214.218
Sales YoY Gr.-NANANA85.6%-65.5%322.1%-1.6%-0.8%55.3%-
Adj EPS -0-0-0.3-00.1-0.1-0.100.10.20.2
YoY Gr.-NANANANA-283.3%NANA366.7%7.1%-
BVPS (₹) 0.100.10.910.90.80.811.11.3
Adj Net
Profit
-0.1-0.1-0.1-0.20.2-0.5-0.20.10.50.61
Cash Flow from Ops. 00-0.1-2-0.21.42.8-3.1-0.70.2-
Debt/CF from Ops. -10.6-10.7-10.9-0.3-4.70.70.1-0.1-6.540.9-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales NA17.2%14.9%55.3%
Adj EPS NA20.1%NA7.1%
BVPS41%2.3%10.3%14.6%
Share Price 15.8% 27.7% -19.6% -63.9%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23TTM
Return on
Equity %
-21.8-27.3-63.2-9.36.3-12.2-6.131514.313.5
Op. Profit
Mgn %
000-4.69.9-1.3-3.21.425.45.4
Net Profit
Mgn %
000-53.7-20.2-2.21.15.94.13.5
Debt to
Equity
2.23.820.30.10.20.30.10.11.21.5-
Working Cap
Days
0004185131,865486441427394181
Cash Conv.
Cycle
00013711496-16131609699

Recent Performance Summary

Return on Equity has increased versus last 3 years average to 13.50%

Sales growth is growing at healthy rate in last 3 years 14.89%

Sales growth is good in last 4 quarters at 89.60%

Net Profit has been subdued in last 3 years 0.00%

Debt to equity has increased versus last 3 years average to 1.49

Latest Financials - Vivanza Biosciences Ltd.

Standalone Consolidated
TTM EPS (₹) 0.2 0.2
TTM Sales (₹ Cr.) 18.1 31.7
BVPS (₹.) 1.3 1.3
Reserves (₹ Cr.) 1 1
P/BV 5.09 5.13
PE 40.63 30.21
From the Market
52 Week Low / High (₹) 5.70 / 17.86
All Time Low / High (₹) 0.05 / 21.00
Market Cap (₹ Cr.) 25.9
Equity (₹ Cr.) 4
Face Value (₹) 1
Industry PE 75.3

Management X-Ray of Vivanza Biosciences:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Vivanza Biosciences

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Sales0003.476.442.229.379.229.1514.21
Operating Expenses 0.050.050.063.645.802.259.669.099.0713.47
Manufacturing Costs0000.020.0900.040.010.100
Material Costs0003.075.531.989.148.568.4812.96
Employee Cost 0000.260.060.020.100.110.080.22
Other Costs 0.050.050.060.280.130.250.390.410.410.29
Operating Profit -0.05-0.05-0.06-0.160.64-0.03-0.300.130.070.74
Operating Profit Margin (%) ----4.6%9.9%-1.3%-3.2%1.4%0.8%5.2%
Other Income 0000.05000.530.500.830.39
Interest 0000.040.370.420.440.470.430.43
Depreciation 00000000.010.010
Exceptional Items 0000000000
Profit Before Tax -0.05-0.05-0.06-0.160.27-0.45-0.200.150.460.69
Tax 00000.03000.0500.12
Profit After Tax -0.05-0.05-0.06-0.160.24-0.45-0.200.100.460.57
PAT Margin (%) ----4.6%3.7%-20.2%-2.2%1.1%5.1%4.0%
Adjusted EPS (₹)0.00.0-0.30.00.1-0.1-0.10.00.10.1
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23

Equity and Liabilities

Shareholders Fund 0.220.170.023.683.923.473.273.373.834.40
Share Capital 3.763.760.194444444
Reserves -3.54-3.59-0.16-0.32-0.08-0.53-0.73-0.63-0.170.40
Minority Interest0000000000
Debt0.390.480.500.530.770.900.180.184.426.56
Long Term Debt0000000000
Short Term Debt0.390.480.500.530.770.900.180.184.426.56
Trade Payables00.050.052.564.845.758.143.865.488.66
Others Liabilities 0.080.050.060.160.140.710.690.530.470.82
Total Liabilities 0.690.740.646.939.6610.8312.287.9314.2120.44

Fixed Assets

Gross Block00000000.020.020.02
Accumulated Depreciation00000000.010.020.02
Net Fixed Assets00000000.0100
CWIP 0000000000
Investments 0001.911.911.911.911.911.911.91
Inventories0001.812.281.910.850.402.231.61
Trade Receivables0002.535.075.546.416.117.3512.18
Cash Equivalents 00.050.03-2.33-3.02-3.03-2.81-3.110.020.10
Others Assets0.680.680.603.013.414.505.922.612.694.62
Total Assets 0.690.740.646.939.6610.8312.287.9314.2120.44

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Cash Flow From Operating Activity -0.04-0.04-0.05-1.98-0.161.372.80-3.08-0.680.16
PBT -0.05-0.05-0.06-0.160.27-0.45-0.200.150.460.69
Adjustment 0000.070.360.430.440.480.410.42
Changes in Working Capital 0.020.010.01-1.9-0.791.392.56-3.65-1.55-0.83
Tax Paid 0000000-0.050-0.12
Cash Flow From Investing Activity 0001.90000-0.0200
Capex 0000000-0.0200
Net Investments 0001.90000000
Others 0000000000
Cash Flow From Financing Activity 0.030.090.02-2.28-0.53-1.38-2.582.800.65-0.08
Net Proceeds from Shares 0000000000
Net Proceeds from Borrowing 0000000000
Interest Paid 000-0.04-0.36-0.42-0.44-0.47-0.41-0.42
Dividend Paid 0000000000
Others 0.030.090.02-2.24-0.17-0.96-2.143.271.060.34
Net Cash Flow -0.010.05-0.02-2.36-0.69-0.010.22-0.30-0.030.09
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Ratios
ROE (%)-25.97-34.4-79.68-8.586.32-12.16-6.053.0112.8913.84
ROCE (%)-9.25-8.96-10.61-4.8814.33-0.636.0717.8315.1911.66
Asset Turnover Ratio0000.920.780.220.820.910.830.82
PAT to CFO Conversion(x)N/AN/AN/AN/A-0.67N/AN/A-30.8-1.480.28
Working Capital Days
Receivable Days000266215872231248269251
Inventory Days00019011634454255249
Payable Days000155244973277256201199

Vivanza Biosciences Ltd Stock News

Vivanza Biosciences Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Vivanza Biosciences on 28-Mar-2024 16:01 is ₹6.79.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 28-Mar-2024 16:01 the market cap of Vivanza Biosciences stood at ₹25.92.
The latest P/E ratio of Vivanza Biosciences as of 28-Mar-2024 16:01 is 40.63.
The latest P/B ratio of Vivanza Biosciences as of 28-Mar-2024 16:01 is 5.09.
The 52-week high of Vivanza Biosciences is ₹17.86 and the 52-week low is ₹5.70.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Vivanza Biosciences is ₹18.13 ( Cr.) .

About Vivanza Biosciences Ltd

Head quartered in Gujarat, Vivanza Biosciences Limited came into existence in April 2016 with the sole aim to further spread its wings in global market with global quality pharmaceutical products at competitive pricing system. It is the bridge between people, Medical Practitioners and the Patients and together it is a healthcare organization dedicated to improving the lives of people globally.

Business area of the company

The company is engaged in the business of business of Pharmaceutical Products.

Products

  • Gloves
  • Surgicals
Read More Read Less
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.